MAPT and Parkinson disease: In Alzheimer’s and Parkinson’s diseases, PM2.5 exacerbates the accumulation of β‐amyloid, hyperphosphorylated tau, and α‐synuclein, while in Huntington’s disease, it worsens toxicity mediated by mutant huntingtin.